Safety and effectiveness of combined antihypertensive and cholesterol-lowering therapy in high-/very high-risk patients

Controlling cardiovascular (CV) risk factors is paramount in reducing atherosclerotic events. This 6-month prospective noninterventional trial assessed the safety and effectiveness of fixed-combination lisinopril-amlodipine plus rosuvastatin. Patients with mild/moderate hypertension and hypercholest...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of comparative effectiveness research 2016-07, Vol.5 (4), p.355-364
Hauptverfasser:	Kónyi, Attila, Sárszegi, Zsolt, Hild, Gábor, Gaszner, Balázs
Format:	Artikel
Sprache:	eng
Schlagworte:	Amlodipine Anticholesteremic Agents - therapeutic use Antihypertensive Agents - therapeutic use cardiovascular risk Cholesterol diabetes mellitus Humans hypercholesterolemia Hypercholesterolemia - drug therapy hypertension Hypertension - drug therapy lisinopril-amlodipine Prospective Studies rosuvastatin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!